Anzeige
Mehr »
Login
Samstag, 18.09.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Rallye gestartet - massive Neubewertung hat gerade begonnen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCDR ISIN: US20451W1018 Ticker-Symbol: 5Y6 
Tradegate
17.09.21
10:57 Uhr
28,100 Euro
-0,300
-1,06 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
COMPASS PATHWAYS PLC ADR Chart 1 Jahr
5-Tage-Chart
COMPASS PATHWAYS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
27,50028,70017.09.
27,80028,50017.09.

Aktuelle News zur COMPASS PATHWAYS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCOMPASS Pathways plc - 6-K, Report of foreign issuer2
COMPASS PATHWAYS Aktie jetzt für 0€ handeln
DiCOMPASS Pathways falls ~4% amid acquisition of psychedelic compounds portfolio2
DiCOMPASS Pathfinder Ltd.: COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs191COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has acquired an...
► Artikel lesen
10.09.COMPASS Pathways hires research scientist Hamilton Morris as consultant3
10.09.COMPASS Pathfinder Ltd.: Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds275COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has engaged Hamilton Morris...
► Artikel lesen
07.09.COMPASS Pathfinder Ltd.: COMPASS Pathways to participate in Citi, Morgan Stanley and HC Wainwright investor conferences in September5
31.08.Innovative Medikamente: Neue Meilensteine in der Medikamenten-Forschung sorgen für weiter steigende Kurse bei dieser Biotech-Firma!
13.08.COMPASS Pathways PLC (CMPS) Investor Presentation - Slideshow23
11.08.COMPASS Pathfinder Ltd.: COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021371Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021 Partnership being developed...
► Artikel lesen
11.08.COMPASS Pathways plc - 6-K, Report of foreign issuer7
07.08.Cannabis-Wissensserie Teil 2: Cannabinoid-Medikamenten gehört die Zukunft! Mit diesem Fonds sind Sie dabei!
05.08.Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 202214
03.08.COMPASS Pathfinder Ltd.: COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences6
30.07.COMPASS Pathways plc - 6-K, Report of foreign issuer11
29.07.COMPASS Pathfinder Ltd.: Guy Goodwin joins COMPASS Pathways as Chief Medical Officer341COMPASS announces changes to its Executive Team London, UK - 29 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient...
► Artikel lesen
21.07.COMPASS Pathfinder Ltd.: Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training384London, UK - 21 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation...
► Artikel lesen
07.07.COMPASS Pathfinder Ltd.: COMPASS Pathways to participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit8
05.07.COMPASS Pathfinder Ltd.: COMPASS Pathways joins forces with King's College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK416London, UK - 5 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has...
► Artikel lesen
30.06.COMPASS Pathfinder Ltd.: COMPASS Pathways launches new podcast "Everyone has a story: talking about mental health"393London, UK - 30 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation...
► Artikel lesen
29.06.Compass Pathways Completes Target Administration Of Psilocybin Therapy In World's Largest Study5
Seite:  Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
5,1,5